Groundbreaking Study Shows Semaglutide Significantly Reduces Kidney Disease, Heart Risks and Mortality in Diabetics
Results from a major clinical trial revealed the diabetes drug semaglutide (Ozempic) significantly reduced the risk of serious kidney disease…